Suppr超能文献

脾动脉支架移植物早期血栓形成

Early Thrombosis of Splenic Artery Stent Graft.

作者信息

Vemireddy Lalitha Padmanabha, Majlesi Delaram, Prasad Sonika, Tahir Nayha, Parkash Om, Jeelani Hafiz Muhammad, Shayuk Maryna

机构信息

Internal Medicine, Chicago Medical School, Chicago, USA.

Internal Medicine, Chicago Medical School, McHenry, USA.

出版信息

Cureus. 2021 Jul 9;13(7):e16285. doi: 10.7759/cureus.16285. eCollection 2021 Jul.

Abstract

Splenic artery aneurysms (SAAs) are among the most common visceral aneurysms behind aortic and iliac arteries. Certain factors like aneurysm size (especially giant SAAs), hypertension (HTN), symptomatology, pregnancy, portal hypertension (pHTN), and liver transplantation increase the risk of rupture. Most often found incidentally, but when symptomatic, can present with nonspecific symptoms like nausea, vomiting, anorexia, and epigastric/left upper quadrant pain. Diagnosis can be accomplished with different modalities of CT or MRI and digital subtraction angiography (DSA) being the gold standard for diagnosis. Treatment is usually preferred for aneurysms >2 cm, symptomatic cases, and pregnant women. Various surgical/interventional procedures can be performed and selected based on the patient's sex, age, location of the aneurysm, size of the aneurysm, and presenting complaints/complications. Endovascular techniques with or without stent-graft placement are being used more, given the minimally invasive nature of these procedures. No clear guidelines exist on initiation of dual antiplatelet therapy (DAPT), but based on guidelines from visceral arterial stenting (especially iliac arteries and renal arteries), multiple case reports/series on SAAs, we highly recommend the usage of DAPT pre- and post-stent-graft placement to improve patency.

摘要

脾动脉瘤(SAA)是继主动脉和髂动脉之后最常见的内脏动脉瘤之一。某些因素,如动脉瘤大小(尤其是巨大脾动脉瘤)、高血压(HTN)、症状表现、妊娠、门静脉高压(pHTN)和肝移植,会增加破裂风险。脾动脉瘤大多是偶然发现的,但出现症状时,可能表现为恶心、呕吐、厌食以及上腹部/左上腹疼痛等非特异性症状。诊断可通过不同方式的CT或MRI完成,数字减影血管造影(DSA)是诊断的金标准。对于直径大于2cm的动脉瘤、有症状的病例以及孕妇,通常首选治疗。可根据患者的性别、年龄、动脉瘤位置、动脉瘤大小以及出现的症状/并发症,选择并实施各种外科/介入手术。鉴于这些手术具有微创性,带或不带覆膜支架置入的血管内技术应用得越来越多。对于双联抗血小板治疗(DAPT)的起始时机,目前尚无明确指南,但根据内脏动脉支架置入(尤其是髂动脉和肾动脉)的指南以及关于脾动脉瘤的多个病例报告/系列研究,我们强烈建议在覆膜支架置入前后使用DAPT,以提高通畅率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/328d/8349697/e41df6909637/cureus-0013-00000016285-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验